Latest News and Press Releases

BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjugates (‘ADCs’), today...

TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research...

BOSTON, Mass, April 01, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjugates (‘ADCs’), today...

BOSTON, Mass, March 31, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjugates (‘ADCs’), today...

New York, United States, March 04, 2025 (GLOBE NEWSWIRE) -- Breast cancer is the prevailing ailment in the population, predominantly affecting women who are witnessing an increase in disease...

Minneapolis, MN, Feb. 11, 2025 (GLOBE NEWSWIRE) -- United Theranostics, a leading provider of radiopharmaceutical therapy and supportive molecular imaging for cancer treatment, is pleased to...

Ori Biotech announces the appointment of two new members to its senior team and new members to its Strategic Advisory Board (SAB).

GAITHERSBURG, Md., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...

Ori Biotech announces the first customer deliveries of the IRO® platform, designed to help address the current challenges in CGT manufacturing.

Woburn, MA, Dec. 31, 2024 (GLOBE NEWSWIRE) -- CellMosaic CEO Dr. Yumei Huang will host a live presentation and Q&A on January 7 at 2:00 PM EST to discuss how the company's breakthrough...